Cefotaxime: pharmacokinetics and in vitro antibacterial activity of serum and urine in normal human volunteers. 1983

J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho

The pharmacokinetic and antibacterial properties of cefotaxime were determined in normal adult volunteers. Single doses of 250, 500, 1,000 and 2,000 mg were evaluated following 5- and 20-min intravenous (i.v.) infusions and intramuscular (i.m.) administration. Cefotaxime was well tolerated and mean peak serum levels exceeded the minimum inhibition concentration (MIC) values for a wide spectrum of potential bacterial pathogens. Approximately 48% of the i.v. doses was excreted renally; average volume of distribution was 30% of body weight and the t 1/2 was about 1 h. Cefotaxime was rapidly absorbed following i.m. injection with maximum serum concentrations occurring at approximately 0.6 h. Serum and urine antibacterial activity reflected the concentration of cefotaxime and MIC of the bacterial pathogens tested.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
September 1980, The Journal of antimicrobial chemotherapy,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
October 1972, Antimicrobial agents and chemotherapy,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
January 1982, Reviews of infectious diseases,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
July 1989, Journal of chemotherapy (Florence, Italy),
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
January 1995, Diagnostic microbiology and infectious disease,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
June 1984, Diagnostic microbiology and infectious disease,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
August 1997, Yao xue xue bao = Acta pharmaceutica Sinica,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
January 1990, Presse medicale (Paris, France : 1983),
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
August 1968, The American journal of the medical sciences,
J F Plouffe, and R L Perkins, and R J Fass, and R B Prior, and B Bernstein, and I Ho
September 1980, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!